Literature DB >> 10330251

Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy.

K D Schlüter1, A Simm, M Schäfer, G Taimor, H M Piper.   

Abstract

The present study investigated the role of early response kinase (ERK) and phosphatidylinositol 3 (PI 3)-kinase in ventricular cardiomyocytes from adult rat for the hypertrophic response to alpha-adrenoceptor stimulation. Parameters of the hypertrophic response were stimulation of protein synthesis and induction of creatine kinase BB. The alpha-adrenoceptor agonist phenylephrine (10 micromol/l) activated ERK2 and PI 3-kinase. The protein kinase C inhibitor bisindolylmaleimide (5 micromol/l) and the mitogen-activated protein kinase kinase inhibitor PD-98059 (10 micromol/l) but not the tyrosine kinase inhibitor genistein (100 micromol/l) blocked ERK2 activation. Inhibition of ERK2 activation abolished induction of creatine kinase BB by phenylephrine but not the increase in protein synthesis. The PI 3-kinase inhibitor wortmannin (100 nmol/l) blocked protein synthesis under alpha-adrenoceptor stimulation but did not interfere with ERK2 activation. Inhibition of the ERK2 pathway with PD-98059 did not affect PI 3-kinase activation. We conclude that ERK2- and PI 3-kinase-dependent pathways represent two mutually exclusive ways of signaling that lead to different aspects of the hypertrophic response to alpha-adrenoceptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330251     DOI: 10.1152/ajpheart.1999.276.5.H1655

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Sex differences in cardiomyocyte connexin43 expression.

Authors:  Brian L Stauffer; Rebecca D Sobus; Carmen C Sucharov
Journal:  J Cardiovasc Pharmacol       Date:  2011-07       Impact factor: 3.105

2.  Knockdown of cyclin-dependent kinase inhibitors induces cardiomyocyte re-entry in the cell cycle.

Authors:  Valeria Di Stefano; Mauro Giacca; Maurizio C Capogrossi; Marco Crescenzi; Fabio Martelli
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  No correlation between the p38 MAPK pathway and the contractile dysfunction in diabetic cardiomyocytes: hyperglycaemia-induced signalling and contractile function.

Authors:  Sibylle Wenzel; Golozar Soltanpour; Klaus-Dieter Schlüter
Journal:  Pflugers Arch       Date:  2005-07-23       Impact factor: 3.657

Review 4.  Adrenergic control of cardiac gap junction function and expression.

Authors:  Aida Salameh; Stefan Dhein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-12       Impact factor: 3.000

5.  Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells.

Authors:  Phillip C Moschella; Vijay U Rao; Paul J McDermott; Dhandapani Kuppuswamy
Journal:  J Mol Cell Cardiol       Date:  2007-10-04       Impact factor: 5.000

6.  Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure.

Authors:  Weihua Zhang; Vijayan Elimban; Mohinder S Nijjar; Suresh K Gupta; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2003

7.  Catecholamine-induced cardiac hypertrophy in rats is associated with the activation of p70 kinase and c-Jun NH(2)-terminal kinase 2.

Authors:  Monika Leicht; Nora Greipel; Beate Raßler; Heinz-Gerd Zimmer
Journal:  Exp Clin Cardiol       Date:  2002

8.  Garlic extracts prevent oxidative stress, hypertrophy and apoptosis in cardiomyocytes: a role for nitric oxide and hydrogen sulfide.

Authors:  Xavier Lieben Louis; Ryan Murphy; Sijo Joseph Thandapilly; Liping Yu; Thomas Netticadan
Journal:  BMC Complement Altern Med       Date:  2012-08-29       Impact factor: 3.659

9.  Identification of the Mtus1 Splice Variant as a Novel Inhibitory Factor Against Cardiac Hypertrophy.

Authors:  Shin Ito; Masanori Asakura; Yulin Liao; Kyung-Duk Min; Ayako Takahashi; Kazuhiro Shindo; Satoru Yamazaki; Osamu Tsukamoto; Hiroshi Asanuma; Masaki Mogi; Masatsugu Horiuchi; Yoshihiro Asano; Shoji Sanada; Tetsuo Minamino; Seiji Takashima; Naoki Mochizuki; Masafumi Kitakaze
Journal:  J Am Heart Assoc       Date:  2016-07-06       Impact factor: 5.501

10.  ADAP1 limits neonatal cardiomyocyte hypertrophy by reducing integrin cell surface expression.

Authors:  Hugo Giguère; Audrey-Ann Dumont; Jonathan Berthiaume; Vanessa Oliveira; Gino Laberge; Mannix Auger-Messier
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.